Polycythemia Vera, Myelofibrosis and Essential Thrombocythemia: Identification of PV, MF & ET Genes

NCT00715247 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 726

Last updated 2019-10-15

No results posted yet for this study

Summary

The purpose of this project is to find genes whose mutations cause Polycythemia Vera, Essential Thrombocythemia and Primary Myelofibrosis.

Conditions

Sponsors & Collaborators

  • Myeloproliferative Disorders-Research Consortium

    collaborator NETWORK
  • National Cancer Institute (NCI)

    collaborator NIH
  • University of Utah

    lead OTHER

Principal Investigators

  • Josef T Prchal, MD · University of Utah

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-07-31
Primary Completion
2018-12-31
Completion
2018-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00715247 on ClinicalTrials.gov